Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Biogen reveals new cell adhesion inhibitor

April 16, 1997

Schering-Plough's Nasonex approved in U.K. and France

April 15, 1997

Nasacort now available for the treatment of allergic rhinitis

April 15, 1997

ABT-761 reduces bronchoconstriction and pulmonary inflammation in animals

April 14, 1997

First CFC-free inhaler launched in U.S.

April 14, 1997

Treatment for rhinitis undergoes further development in Australia

April 11, 1997

Norastemizole demonstrates high efficacy, safety and rapid onset of action in humans

April 10, 1997

New LTD4 antagonist from Fujisawa

April 10, 1997

Dual H1/PAF antagonists disclosed by British Biotech

April 10, 1997

Quinolone PDE IV/TNF inhibitors from Chiroscience

April 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.